Evinature is proud to announce that our co-founder, Nir Salomon, recently took part in a 40-minute Instagram Live interview with Liam Robertson (@livingwithulcerativecolitis), a published author and well-known advocate for people living with Inflammatory Bowel Disease (IBD) who himself has Ulcerative Colitis. The interview delved into the origins of Evinature, the science behind our signature CurQD® Protocol, and exciting plans for the future of gut health solutions.
During their discussion, Nir shared his personal background and the catalysts that led him and his team to create Evinature. Liam asked about the science behind CurQD®—how it works, what sets its formulation apart, and the reasons behind its price point. Nir also spoke about clinical trials completed so far and hinted at ongoing research designed to further validate CurQD®’s efficacy.
The conversation then touched on insurance coverage, including the possibility of having CurQD® covered by health plans in the U.S. and potentially through the UK’s NHS. Nir highlighted Evinature’s other products, such as
DivertX (formulated for IBS, IBS-like symptoms, and Diverticulitis) and Exhale (formulated for anxiety and stress relief), and shared a glimpse into the future roadmap for the company.
He elaborated on how DivertX is intended not only to relieve gut inflammation but also to rebalance the bacteria in your digestive system. When addressing Exhale, Nir and Liam discussed the gut-brain connection, its impact on conditions like IBD, and how Exhale combines natural compounds to acheive stress relief.
By continuing to make clinically-proven, evidence-based and natural gut health solutions accessible, Evinature remains committed to reshaping the standard of care for IBD and beyond. If you missed the live session, stay tuned for more updates from Evinature. We’ll be sharing key takeaways and future opportunities to connect with our experts as we continue to innovate for better gut health around the world.
Evinature
